CVE-2025-46487

WordPress EC Authorize.net plugin <= 0.3.3 - Reflected Cross Site Scripting (XSS) vulnerability

7.1 High

Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') vulnerability in sftranna EC Authorize.net ec-authorizenet allows Reflected XSS.This issue affects EC Authorize.net: from n/a through <= 0.3.3.

Attack profile

How easy it is to exploit

Attack vector: Network
Complexity: Low
Privileges needed: None
User interaction: Required

What an attacker can affect

Confidentiality: Low
Integrity: Low
Availability: Low

Exploit likelihood

0.28%Up 0.2 points since May 24, 2025

What each source reports

CVE List Score used 7.1

WordPress EC Authorize.net plugin <= 0.3.3 - Reflected Cross Site Scripting (XSS) vulnerability

Record: CVE-2025-46487
CVSS 3.1: 7.1 HighCVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:L
Weakness: CWE-79
Updated: 2026-11-02

EUVDEUVD-2025-28053 7.1

Record: EUVD-2025-28053
CVSS 3.1: 7.1 HighCVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:L
Updated: 2026-11-02

GitHub AdvisoriesGHSA-c33v-v5r9-774j 7.1

Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting')...

Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') vulnerability in sftranna EC Authorize.net allows Reflected XSS. This issue affects EC Authorize.net: from n/a through 0.3.3.

Record: GHSA-c33v-v5r9-774j
CVSS 3.1: 7.1 HighCVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:L
Weakness: CWE-79
Updated: 2026-11-02

NVD 7.1

Record: CVE-2025-46487
CVSS 3.1: 7.1 HighCVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:L
Weakness: CWE-79
Updated: 2026-11-02

Affected products

sftranna ec authorize.net

History

History
Recorded	Changed	Sources
Nov 2, 2026	first indexed	CVE List, EUVD, GitHub Advisories, NVD

Dates are when Every CVE recorded each change. Upstream dates may differ.

In short

CVE-2025-46487 is a high vulnerability (CVSS 7.1) in Sftranna Ec Authorize.net, published May 23, 2025. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 0.28%, the 20th percentile. No source names a fixed version.